 The drug, Denanumab, is approved for patients with early or mild cases of Alzheimer's, the most common type of dementia. Eli Lilly's drug can slow the disease that destroys memory for about seven months, and it's given once a month. Patients can stop using it if they respond well, but there are potentially dangerous side effects, including brain swelling and brain bleeds. Allison Keys, CBS News.